JAN 24, 2020 8:37 AM PST

Immune "Recycling" Could Improve Cancer Immunotherapy

WRITTEN BY: Kara Marker

A natural housekeeping function performed by many cells of the human body, including those in the immune system, is under intense scrutiny for its potential to create more robust immunotherapy for treating cancer.

Cells like T lymphocytes of the immune system perform autophagy on a regular basis as a “recycling” mechanism for breaking down cellular debris. These simple housekeeping cellular interactions, described in a 2019 review article published in Frontiers in Cell and Developmental Biology as a “essential degradative process,” may hold the key to improving current immunotherapy technology because of the potential to secure healthy cellular functioning by removing and replacing worn out organelles, like mitochondria.

Researchers are hopeful that utilizing autophagy could help improve efficacy of cancer immunotherapy, a technique that harnesses that natural power of the human immune system to fight cancer. Giving the immune system the tools it needs to fight cancer off on its own is often a less toxic option than chemotherapy or radiation.

In this study, researchers looked specifically at live-resident T cells and their autophagy activity. This is a specific population of T cells that live exclusively in the liver and have adapted to its unique environment. In more ways than one, liver T cells help protect the organ from chronic viral infections. With autophagy, T cells support cellular nutrition and renewal of organelles like mitochondria.

"T cells living within the liver must adapt to the stressful microenvironment, with low levels of oxygen and an abundance of inhibitory signals, to find ways of maintaining prolonged survival and functionality,” explained corresponding author Dr. Leo Swadling.

Swadling and the rest of the research team found that liver-resident T cells are particularly skilled at autophagy – functioning at an “enhanced rate.” They also found that interleukin (IL)-15 cytokines, “soluble messenger proteins,” are pulling the strings, building this skillset for the T cells. This study is the first to identify IL-15 as able to “boost” autophagy in human T cells.

The impact of this identification is clear: the potential to improve existing immunotherapy techniques (like CAR T cell therapy) by improving T cell health and survival. Researchers could implement the same T cell autophagy observed in the liver to boost strength of T cells extracted from the blood for immunotherapy by exposing them to IL-15.

Sources: University College London, Cell Reports

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 20, 2020
Health & Medicine
MAR 20, 2020
Why Does COVID-19 Kill So Many Older People?
Since early statistics began to emerge from China, it seemed that COVID-19 tended to affect older people more than young ...
APR 16, 2020
Health & Medicine
APR 16, 2020
Structural Basis of Receptor Recognition by SARS-CoV-2
As mortality and infection rates rise globally, it appears that SARS-CoV-2, the virus responsible for the COVID-19 pande ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
MAY 02, 2020
Immunology
MAY 02, 2020
Cellular "Cleaning Crews" Get Busy During Spinal Cord Injury
  Nerve cells transmit and receive information traversing the human body in the form of electrical impulses. These ...
MAY 07, 2020
Immunology
MAY 07, 2020
New COVID-19 Vaccine Defends Monkeys Against Infection
Researchers from Beijing-based Sinovac Biotech have reported preliminary results of a study into the development of a va ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
Loading Comments...